Downregulated SOX21-AS1 may potentially increase the expression of FZD3/5 by activating the Wnt signaling pathway, ultimately contributing to the alleviation of hippocampal neuronal oxidative stress, reducing the apoptosis rate and enhancing the learning and memory abilities of mice with AD. This evidence concerns the gene FZD3 and Alzheimer disease.